Work

Real-World Safety Profile of Ibrutinib in Chronic Lymphocytic Leukemia: A Focus on Adverse Events, Discontinuations, and Effectiveness Outcomes

Year: 2025

Type: article

Study design: Observational Study

Source: Annals of Pharmacotherapy

DOI: 10.1177/10600280251334133

Authors: Alejandro Martínez Pradeda, Pablo Feijoo Vilanova, Elena Fernández Gabriel, Víctor Giménez Arufe, Ana María Vale López, Jorge Suanzes-Hernández, Luis Margusino-Framiñán, Víctor Noriega Concepción

Institutions: Universidade da Coruña, Complexo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica de A Coruña

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410716949

FWCI: 0.531

Cites: 27

Cited by: 1

Related to: 10